Double-hit and triple-hit B-cell lymphomas are generally associated with poor prognosis although a more favorable outcome has been reported for a patient with MBNL1::BCL6 in whom absence of BCL6 overexpression was also noted [6,9,31]. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.